SS
VIR icon

SBI Securities’s Vir Biotechnology VIR Stock Holding History

SBI Securities’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Sell
4,122
-34
-0.8% -$323 ﹤0.01% 1238
2026
Q1 		$37.2K Sell
4,156
-2,298
-36% -$18.3K ﹤0.01% 1214
2025
Q4 		$38.9K Sell
6,454
-1,632
-20% -$9.72K ﹤0.01% 1180
2025
Q3 		$46.2K Sell
8,086
-153
-2% -$782 ﹤0.01% 1119
2025
Q2 		$41.5K Buy
8,239
+84
+1% +$450 ﹤0.01% 1121
2025
Q1 		$52.8K Sell
8,155
-67
-0.8% -$596 ﹤0.01% 956
2024
Q4 		$60.3K Buy
+8,222
New +$64.9K ﹤0.01% 917

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBI Securities's VIR Position: Q2 2026 in Review

SBI Securities reduced its Vir Biotechnology (VIR) stake by 0.82% in Q2 2026, selling an estimated $323 and leaving 4,122 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

SBI Securities first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. The position peaked at $60.3K in Q4 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • SBI Securities held 4,122 shares of Vir Biotechnology worth $42K as of Q2 2026.
  • SBI Securities sold 34 Vir Biotechnology shares in Q2 2026, an estimated $323.
  • Vir Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1238 holding.
  • SBI Securities first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Vir Biotechnology position peaked at $60.3K in Q4 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.